The Monitoring of Protein Markers of Inflammation and Serum Lipid Concentration in Obese Subjects with Metabolic Syndrome
Authors:
Open Access
- 28 August 2017
- journal article
- research article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 36 (4) , 366-374
Abstract
Summary: Background: Obesity is one of the most common modern health problems worldwide. Proinflammatory cells accumulate in the adipose tissue of the obese, and the presence of a low level chronic inflammation in obesity is associated with the emergence of a range of metabolic disorders in cluding cardiovascular disease, insulin resistance, type-2 diabetes, fatty-liver disease, and others. Neutrophils are early parti - cipants in inflammatory processes. After the appropriate stimu lation, these cells release reactive oxygen and nitrogen species, which leads to degranulation and secretion of myeloperoxidase and other enzymes. Myelo per oxidase and its reactive oxidants contribute to tissue damage during inflammatory processes in the human body. Methods: The study included 175 subjects who were, in com - pliance with the International Diabetes Federation criteria, divided into 3 groups: normal weight subjects (N=106), subjects with abdominal obesity (N=37) and the third group consisted of subjects with the metabolic syndrome (N=32). Results: By analyzing the myeloperoxidase enzyme activity (kU/L), and the levels of high-sensitivity C-reactive protein in the blood of all subjects, we detected their significantly higher activity and levels in subjects with the metabolic syndrome, as compared to normal weight subjects (p<0.001). Conclusion: Based on our results, we can conclude that the MPO activity in the serum progressively increases with obesity and the metabolic syndrome, which indicates that this prooxidant enzyme may play a role in the pathophysiological mechanisms of the obesity and the metabolic syndrome related complications.Keywords
This publication has 33 references indexed in Scilit:
- Dyslipidemia in Obesity: Mechanisms and Potential TargetsNutrients, 2013
- Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean womenClinical Biochemistry, 2012
- Inflammatory links between obesity and metabolic diseaseJournal of Clinical Investigation, 2011
- Body-Mass Index and Mortality among 1.46 Million White AdultsNew England Journal of Medicine, 2010
- Insulin resistance is a risk factor for high blood pressure regardless of body size and fat distribution in obese childrenNutrition, Metabolism and Cardiovascular Diseases, 2010
- Adipose tissue as an endocrine organMolecular and Cellular Endocrinology, 2010
- Myeloperoxidase, modified lipoproteins, and atherogenesisJournal of Lipid Research, 2009
- Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy IndividualsJACC, 2007
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Statins downregulate myeloperoxidase gene expression in macrophagesBiochemical and Biophysical Research Communications, 2005